ETView Medical enters distribution agreement with Stopler Belgium

ETView Medical Ltd. (TASE: ETVW), a commercial stage medical device company traded on the Tel Aviv stock exchange, announced today that it has entered into a distribution agreement with Stopler Belgium. The agreement enables Stopler to market ETView's lead product, TVT™, for a period of three years in Belgium. ETView's TVT™ combines high-flow ventilation airway management with continuous video monitoring to overcome current limitations and associated adverse surgical events during lung isolation surgeries. Other terms were not announced.

Stopler Belgium is a division of the SIMED Group (Stopler International Medical), a European based diversified health care provider, with a wide range of activities including distribution of medical equipment in Holland and Belgium.

Arie Ben-Josef, CEO of ETView Medical, commented, "We are excited to add Stopler Belgium to our expanding distributor network." Mr. Ben-Josef continued, "The TVT™ product family is currently being distributed across Europe and the United States. ETView will continue to provide best-in-class airway management solutions for sophisticated thoracic surgical procedures through TVT™ and additional technologies under development."

Source:

Stopler Belgium

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.